Background: Multipotent mesenchymal stromal cells (MSC) enhance viability and function of islets of Langerhans. We aimed to examine the interactions between human MSC and human islets of Langerhans that influence the function of islets. Methods: Human MSC and human islets (or pseudoislets, obtained after digestion and reaggregation of islet cells) were cocultured with or without cellular contact and glucose-stimulated insulin secretion assays were performed to assess cell function. The expression of several adhesion molecules, notably ICAM-1 and N-cadherin on islets and MSC, was investigated by qPCR. The role of N-cadherin was analyzed by adding an anti-N-cadherin antibody in islets cultured with or without MSC for 24 h followed by insulin ...
The clinical usability of pancreatic islet transplantation for the treatment of type I diabetes, des...
Aims/hypothesis: Novel strategies to stimulate the expansion of beta cell mass in situ are warranted...
Previously, pharmacological activation of Wnt-signaling in human bone marrow-derived multipotent str...
Abstract Background Multipotent mesenchymal stromal c...
Multipotent mesenchymal stromal cells (MSC) seems promising for the treatment of numerous diseases. ...
Mesenchymal stromal cells (MSCs) represent an interesting tool to improve pancreatic islet transplan...
Aims/hypothesis: Islet transplantation is used therapeutically in a minority of patients with type 1...
Islet transplantation is an established clinical procedure for select patients with type 1 diabetes ...
Islet transplantation is an established clinical procedure for select patients with type 1 diabetes ...
The aim of this study was to assess whether cadherin-mediated adhesion of human islet cells was affe...
Islet transplantation is used therapeutically in a minority of patients with type 1 diabetes. Succes...
The clinical usability of pancreatic islet transplantation for the treatment of type I diabetes, des...
Background: Mesenchymal stromal cells (MSC) have been under investigation for a number of therapies ...
In Type 1 Diabetes (T1D), insulin-producing beta cells are lost due to a T-cell mediated autoimmune ...
The clinical usability of pancreatic islet transplantation for the treatment of type I diabetes, des...
The clinical usability of pancreatic islet transplantation for the treatment of type I diabetes, des...
Aims/hypothesis: Novel strategies to stimulate the expansion of beta cell mass in situ are warranted...
Previously, pharmacological activation of Wnt-signaling in human bone marrow-derived multipotent str...
Abstract Background Multipotent mesenchymal stromal c...
Multipotent mesenchymal stromal cells (MSC) seems promising for the treatment of numerous diseases. ...
Mesenchymal stromal cells (MSCs) represent an interesting tool to improve pancreatic islet transplan...
Aims/hypothesis: Islet transplantation is used therapeutically in a minority of patients with type 1...
Islet transplantation is an established clinical procedure for select patients with type 1 diabetes ...
Islet transplantation is an established clinical procedure for select patients with type 1 diabetes ...
The aim of this study was to assess whether cadherin-mediated adhesion of human islet cells was affe...
Islet transplantation is used therapeutically in a minority of patients with type 1 diabetes. Succes...
The clinical usability of pancreatic islet transplantation for the treatment of type I diabetes, des...
Background: Mesenchymal stromal cells (MSC) have been under investigation for a number of therapies ...
In Type 1 Diabetes (T1D), insulin-producing beta cells are lost due to a T-cell mediated autoimmune ...
The clinical usability of pancreatic islet transplantation for the treatment of type I diabetes, des...
The clinical usability of pancreatic islet transplantation for the treatment of type I diabetes, des...
Aims/hypothesis: Novel strategies to stimulate the expansion of beta cell mass in situ are warranted...
Previously, pharmacological activation of Wnt-signaling in human bone marrow-derived multipotent str...